abstract |
The present invention provides the use of inhaled pharmaceutical compositions containing roflumilast N-oxide for the treatment of autoimmune, respiratory and / or inflammatory diseases and conditions, and a method for treating these diseases and conditions, including inhalation of roflumilast N-oxide or a pharmaceutically acceptable salt thereof thereof characterized by less than 6 μm and administered as a single dose of about 5 to about 2000 μg. |